D'Anchise Roberto, Bulitta Michael, Giannetti Bruno
Istituto Ortopedico Galeazzi, Milano, Italy.
Arzneimittelforschung. 2007;57(11):712-6. doi: 10.1055/s-0031-1296672.
A previously published study comparing the efficacy of comfrey extract to a commercial diclofenac (CAS 78213-16-8) preparation in the treatment of unilateral ankle sprains is critically re-evaluated. The study was designed to show non-inferiority of the comfrey extract. The data were re-evaluated for superiority according to CPMP guidelines. The study was an observer-blind, randomised, multi-centre clinical trial with two independent treatment groups "comfrey extract" and "diclofenac gel" (parallel group design) and included a total of 164 patients (82 in the comfrey group and 82 in the diclofenac group, intention-to-treat (ITT) analysis). Key variables were the area under the curve (AUC) from Visits 1 to 2 of the difference of the tenderness values contra-lateral minus injured side (primary variable), pain assessment (Visual Analogue Scale, VAS) at rest and on movement by patient, swelling (figure-of-eight method) and ankle movement (neutral zero method). On average (mean difference comfrey extract minus diclofenac), the AUC was +61.1 h x N/cm2 greater for patients treated with comfrey extract compared to diclofenac treated patients (95% confidence interval: 19.08; 103.09 h x N/cm2). The difference between the two treatment groups was statistically significant (analysis of variance with factors "study drug", "centre", and "drug x centre interaction"). Safety was excellent in both treatment groups. The re-evaluation of the data showed superiority of the plant based ointment over the diclofenac gel in the treatment of distortions. It is encouraging and impressive to realize that a natural product seems to be an effective and safe alternative to the standard topical treatment with diclofenac.
对一项先前发表的研究进行了批判性重新评估,该研究比较了紫草提取物与市售双氯芬酸(CAS 78213-16-8)制剂治疗单侧踝关节扭伤的疗效。该研究旨在证明紫草提取物的非劣效性。根据欧洲药品评价局(CPMP)指南对数据进行了优效性重新评估。该研究是一项观察者盲法、随机、多中心临床试验,有两个独立治疗组“紫草提取物”和“双氯芬酸凝胶”(平行组设计),共纳入164例患者(紫草组82例,双氯芬酸组82例,意向性分析(ITT))。关键变量包括从第1次访视到第2次访视时对侧压痛值减去患侧压痛值差值的曲线下面积(AUC)(主要变量)、患者休息和活动时的疼痛评估(视觉模拟评分法,VAS)、肿胀(8字法)和踝关节活动度(中立零点法)。平均而言(紫草提取物减去双氯芬酸的平均差值),与双氯芬酸治疗的患者相比,紫草提取物治疗的患者AUC大+61.1 h×N/cm²(95%置信区间:19.08;103.09 h×N/cm²)。两个治疗组之间的差异具有统计学意义(采用“研究药物”、“中心”和“药物×中心交互作用”因素的方差分析)。两个治疗组的安全性均良好。数据重新评估显示,在治疗扭伤方面,植物性软膏优于双氯芬酸凝胶。认识到一种天然产品似乎是双氯芬酸标准局部治疗的有效且安全的替代品,这令人鼓舞且印象深刻。